Need Help? Call 1­-866-­796-­7386
« back to stock screener

  PDLI stock: PDL BioPharma Inc

Current Rating
Strong Sell

Previous Rating:

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$2.08
Market Cap
397.3M
Sector
Health Care
Div. Growth
-58.30%
P/E
2.2
P/B
0.5
P/S
1.05
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
156.1K
FCF
-
Op. Margin
85.70%
Net Margin
49.00%
ROE
23.90%
ROI
37.80%
ROA
16.10%
EPS Growth
-39.80%
Current Ratio
7.7
Debt/Equity
32.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Reliv International, Inc (RELV) $4.43 - - 8M Strong Buy
VIVUS, Inc. (VVUS) $1.39 - - 137.3M Strong Buy
AngioDynamics, Inc. (ANGO) $16.74 - - 627.7M Strong Buy
Fibrocell Science Inc (FCSC) $0.78 - - 42.2M Strong Buy
Eleven Biotherapeutics Inc (EBIO) $2.41 - - 58.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More